Loading...
Interleukin‐6 Inhibitor, Tocolizumab, for COVID‐19: evidence review of the clinical benefit and harm
Interleukin‐6 Inhibitor, Tocolizumab, for COVID‐19: evidence review of the clinical benefit and harm
Parrish, A. Gray, A. Kredo, T. Maartens, G. Reubenson, G. Cohen, K. De Waal, R. Blockman, M. Nel, J. Rees, H.
Parrish, A.
Gray, A.
Kredo, T.
Maartens, G.
Reubenson, G.
Cohen, K.
De Waal, R.
Blockman, M.
Nel, J.
Rees, H.
Abstract
Description
Date
2020-04-15
Journal Title
Journal ISSN
Volume Title
Publisher
South African National Department of Health